Erasca, Inc. financial data

Symbol
ERAS on Nasdaq
Location
10835 Road To The Cure, Suite 140, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.1K % -12.1%
Debt-to-equity 18.4 % -18.6%
Return On Equity -31.2 % +31.3%
Return On Assets -26.3 % +28.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 284M shares +0.41%
Common Stock, Shares, Outstanding 284M shares +3.89%
Entity Public Float 563M USD +89.5%
Common Stock, Value, Issued 28K USD +3.7%
Weighted Average Number of Shares Outstanding, Basic 283M shares +30.1%
Weighted Average Number of Shares Outstanding, Diluted 283M shares +30.1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 38.3M USD -6.63%
Operating Income (Loss) -147M USD +16.2%
Nonoperating Income (Expense) 18.4M USD +9.19%
Net Income (Loss) Attributable to Parent -128M USD +19%
Earnings Per Share, Basic 0 USD/shares +56.5%
Earnings Per Share, Diluted 0 USD/shares +56.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.1M USD -61.7%
Marketable Securities, Current 235M USD -0.46%
Cash, Cash Equivalents, and Short-term Investments 387M USD -5.31%
Assets, Current 311M USD -25.7%
Property, Plant and Equipment, Net 14.8M USD -17.6%
Operating Lease, Right-of-Use Asset 30.8M USD -8.14%
Other Assets, Noncurrent 2.59M USD -34.6%
Assets 445M USD -15.3%
Accounts Payable, Current 1.66M USD -22.4%
Liabilities, Current 28.2M USD +13.1%
Operating Lease, Liability, Noncurrent 44.7M USD -10%
Other Liabilities, Noncurrent 263K USD +221%
Liabilities 73.1M USD -2.05%
Accumulated Other Comprehensive Income (Loss), Net of Tax 415K USD
Retained Earnings (Accumulated Deficit) -833M USD -18.2%
Stockholders' Equity Attributable to Parent 372M USD -17.5%
Liabilities and Equity 445M USD -15.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +5.1%
Net Cash Provided by (Used in) Financing Activities 6.93M USD +3687%
Net Cash Provided by (Used in) Investing Activities 34.3M USD +244%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 284M shares +3.84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.74M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 66.6M USD -61.6%
Deferred Tax Assets, Valuation Allowance 180M USD +25.2%
Deferred Tax Assets, Gross 190M USD +21.7%
Operating Lease, Liability 49.4M USD -8.42%
Payments to Acquire Property, Plant, and Equipment 83K USD +97.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -128M USD +19%
Lessee, Operating Lease, Liability, to be Paid 67M USD -12%
Property, Plant and Equipment, Gross 26.3M USD -0.19%
Operating Lease, Liability, Current 4.71M USD +9.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.2M USD +0.32%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.04M USD +0.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.6M USD -20.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.28M USD +0.85%
Deferred Tax Assets, Operating Loss Carryforwards 70.1M USD +18.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 80M shares 0%
Unrecognized Tax Benefits 5.41M USD +32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.57M USD +3.18%
Operating Lease, Payments 1.5M USD -28.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.32M USD -16.7%
Share-based Payment Arrangement, Expense 26.1M USD -1.31%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%